FDA Warns About Compounded Versions of Ozempic and Wegovy
XTalks
JUNE 5, 2023
Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). Ozempic was approved for the management of type 2 diabetes mellitus in adults in addition to a reduced-calorie diet and exercise. mg and 2.4 mg doses of Wegovy.
Let's personalize your content